Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine.
Biomedicines. 2022 Oct 20;10(10):2654. doi: 10.3390/biomedicines10102654.
Biomedicines. 2022.
PMID: 36289916
Free PMC article.
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC.
Ruzzi F, Angelicola S, Landuzzi L, Nironi E, Semprini MS, Scalambra L, Altimari A, Gruppioni E, Fiorentino M, Giunchi F, Ferracin M, Astolfi A, Indio V, Ardizzoni A, Gelsomino F, Nanni P, Lollini PL, Palladini A.
Ruzzi F, et al. Among authors: semprini ms.
Transl Lung Cancer Res. 2022 Nov;11(11):2216-2229. doi: 10.21037/tlcr-22-163.
Transl Lung Cancer Res. 2022.
PMID: 36519016
Free PMC article.
Item in Clipboard
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Ruzzi F, Semprini MS, Scalambra L, Palladini A, Angelicola S, Cappello C, Pittino OM, Nanni P, Lollini PL.
Ruzzi F, et al. Among authors: semprini ms.
Int J Mol Sci. 2023 Aug 19;24(16):12963. doi: 10.3390/ijms241612963.
Int J Mol Sci. 2023.
PMID: 37629147
Free PMC article.
Review.
Item in Clipboard
Cite
Cite